ncd 38

NCD38 is a potent, selective LSD1 inhibitor.

Hexamethonium tartrate is a nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.

NCD38 TFA为LSD1的选择性抑制剂，具有高亲和力和特异性。

Anti-Human-CD38 Antibody (Daratumumab hexabody)是一种抗体，其表达系统是 HEK293 cells，同型对照是 IgG1, Kappa。

Daratumumab 是一种首创的特异性抗CD38单克隆抗体。它损伤了 MM 细胞的粘附，从而增加了 MM 对蛋白酶体抑制的敏感性。它具有抗多发性骨髓瘤(MM) 的作用。